Navigation Links
Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues

NEW YORK, May 12 /PRNewswire-USNewswire/ -- The Alliance for Lupus Research (ALR) commends the Senate on its passage of a resolution supporting the goals and ideals of National Women's Health Week that begins annually on Mother's Day. The resolution, introduced by Senators Russ Feingold (D-WI) and Olympia Snowe (R-ME) calls on all Americans to take the week of May 11th - May 17th as an opportunity to educate themselves on women's health issues, and recognizes the importance of Federally funded programs that provide research on common diseases in women, like lupus. ALR's main legislative priority is increased support for lupus research by Federal agencies such as the National Institute for Health, Health and Human Services, and Department of Defense Health Programs. The House version of the resolution introduced by Rep. Maurice Hinchey (NY-D) is expected to pass this week.

"Too many women - our nation's mothers, daughters, sisters, and grandmothers - are affected by lupus, a devastating autoimmune disease. We are pleased that Congress is honoring National Women's Health Week along with the ALR, by officially recognizing the importance of education and continued Federal research funding for lupus and other women's health issues," says ALR President Barbara Boyts.

Lupus causes unpredictable symptoms ranging from fatigue and joint pain to severe organ damage, and complications from the disease often prove fatal. The resolution properly recognizes that significant disparities exist in the prevalence of disease among women of different backgrounds. Not only are women in their childbearing years nine times more likely than men to develop lupus, but women of African-American descent are three times more likely to be diagnosed with the disease. Women of Asian, Latin American/Hispanic, Pacific Rim descent are also more likely to be affected. An estimated 1.4 million Americans have lupus.

"This disease disproportionately strikes a typically medically underserved portion of America's population. It is vital that American women are aware of diseases more common in women, take care of their health, and talk to their doctors about symptoms that might be part of a more serious condition," says ALR's Scientific Advisory Board Chair, Dr. Mary K. Crow. "Lupus can cause heart and kidney disease - two leading causes of death for women - so we are grateful to our Members of Congress for shining a light on this important issue."

The Alliance for Lupus Research (ALR) is a national voluntary health organization based in New York City and founded in 1999. Chaired by Robert Wood Johnson IV, it has become the world's largest private source of lupus research funds and has committed $50 million to lupus-specific research projects since its inception. The organization's mission is to find better treatments and ultimately prevent and cure lupus by supporting medical research. Because the ALR's Board of Directors pays for all administrative and fundraising costs, 100% of all donations go directly to support lupus research programs. For more information, visit

SOURCE Alliance for Lupus Research
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Statement From the Lupus Foundation of America Regarding the Release of Top-Line Results From a Study of Rituxan for the Treatment of Lupus
2. Rigels R788 Slows Progression of Murine Lupus in Preclinical Studies
3. Steps Toward Stopping Autoimmune Disease: International Consortium Identifies Genes Linked to Lupus
4. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
5. Human Genome Sciences Reports Positive Data from Long-Term Treatment with LymphoStat-B(R) in Patients with Active Systemic Lupus Erythematosus
6. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
7. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
8. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
9. Aida Announces New Anti-Cancer Drug Under Development
10. Michael J. Fox Foundation Commits up to $10 Million for Pre-Clinical Drug Development Under Therapeutics Development Initiative
11. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
Post Your Comments:
(Date:11/27/2015)... 27, 2015 --> ... go online. The potential to save costs, improve treatment ... far from fully exploited as yet. Here, particular emphasis ... either via mobile tablet or directly at the patients, ... ) -->      (Photo: ...
(Date:11/27/2015)... , Nov. 26, 2015 ... addition of the "2016 Global Tumor ... Country Volume and Sales Segment Forecasts, Innovative ... report to their offering. --> ... of the "2016 Global Tumor Marker ...
(Date:11/26/2015)... 2015 --> ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... that immunotherapy can be efficiently combined with photodynamic therapy ...
Breaking Medicine Technology:
(Date:11/27/2015)... , ... November 27, 2015 , ... CBD College ... of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. ... accredited colleges, as only one of twelve colleges and universities in the state of ...
(Date:11/27/2015)... ... , ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his search ... one of Joplin's most famous and beautiful concert posters. The concert was held on ... Arbor. The According to Hawley, "It is hard to believe that Joplin's stardom was ...
(Date:11/26/2015)... Las Vegas, NV (PRWEB) , ... November 26, 2015 , ... ... holiday shopping strategy. Many customers choose to buy during the Black Friday and ... holiday gifts. Shoppers don’t need to search the Internet high and low to find ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
(Date:11/26/2015)... ... 26, 2015 , ... WorldCare International, Inc., the first company ... Employee Benefits Conference. The Employee Benefits Conference was hosted by the International Foundation ... 11th, 2015. The conference was held at the Hawaii Convention Center in Honolulu, ...
Breaking Medicine News(10 mins):